CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol. 2014;20(3):274-282.   Published online 2014 September 25    DOI: https://doi.org/10.3350/cmh.2014.20.3.274

Excel Download

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Clinical and Molecular Hepatology. 2014;20(3):274   Crossref logo
Link1 Link2

504 Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B
Journal of Hepatology. 2005;42:182   Crossref logo
Link1 Link2

Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine
Journal of Viral Hepatitis. 2008;15(12):922-924   Crossref logo
Link1

Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis
Liver International. 2008;28(6):814-820   Crossref logo
Link1

Rescue therapy for lamivudine-resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy
Journal of Gastroenterology and Hepatology. 2010;25(8):1374-1380   Crossref logo
Link1

Adefovir plus lamivudine combination therapy in lamivudine-resistant chronic hepatitis B
The Korean Journal of Hepatology. 2008;14(2):235   Crossref logo
Link1 Link2

501 Adefovir dipivoxil alone or in combination with lamivudine in HBeAg negative patients with lamivudine resistant chronic hepatitis B: A prospective, randomized study
Journal of Hepatology. 2005;42:181   Crossref logo
Link1 Link2

101 High levels of HBsAg clearance after adefovir dipivoxil treatment in patients with chronic hepatitis B lamivudine-resistant post liver transplant
Journal of Hepatology. 2005;42:44   Crossref logo
Link1 Link2

Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates
Liver Transplantation. 2013;19(3):268-274   Crossref logo
Link1 Link2

Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern
Journal of Viral Hepatitis. 2011;18(3):206-215   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.